CKD-828(80/2.5mg) Pharmacokinetic Study
NCT01246193
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
CKD-828(FDC)
DRUG:
Combination Therapy
Sponsor
Chong Kun Dang Pharmaceutical